MGMarcus Gertzen

Marcus Gertzen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcus Gertzen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sexual Health in Psychiatry: Bridging the Communication Gap and Training Needs between Patients and Clinicians – A Cross-Sectional Exploratory Pilot Study

    by Teresa Schweitzer, Peter Martl, Douglas Dubrovin Leão, Lena Hammerl, Theresa Halms, Katharina Domani, Sophia Vom Baur, Anna-Sophia Eder, Andrea Rabenstein, Tobias Rüther, et al.

    Sexual health is integral to mental well-being, yet it remains under-addressed in psychiatric care. Mental disorders and psychotropic medications can cause sexual dysfunctions. Despite its clinical relevance, sexual health is often not routinely assessed or discussed in psychiatric assessment and treatment, possibly due to insufficient training, stigma, and clinicians’ uncertainty. This pilot study examined how sexuality is addressed in psychiatric treatment and how relevant the topic is perceived, integrating patient and clinician perspectives. A cross-sectional, anonymous online survey was conducted between February and July 2025 in two German academic psychiatric hospitals. Psychiatric patients and mental-health professionals completed questionnaires tailored to their perspectives. Patients completed measures of sexual functioning, well-being, and communication about sexuality, whereas mental-health professionals completed measures of attitudes, clinical practice, and professional training. Data were analysed using descriptive and inferential statistics. A total of 231 patients and 194 clinicians participated. Nearly all patients reported at least one sexual dysfunction (100% women, 97% men), while only 18.7% reported being sexually satisfied. Although most patients (62.0%) considered sexuality an important topic, only 12.5% reported that it had been addressed. Clinicians reported addressing sexuality more frequently (psychotherapists: 44.0%; specialists: 62.1%). Among physicians, confidence and years of professional experience predicted actively discussing sexual issues ( p = .013). More than 80% of clinicians reported insufficient coverage of sexual health during their education. Sexual health remains a neglected domain in psychiatric care despite being recognized as important by both patients and clinicians. Strengthening clinicians’ confidence through targeted training, routine screening, and institutional support may help normalize the assessment of sexual health as part of holistic, patient-centred psychiatric care.

  • Open Access

    Lethal Lust: Suicidal Behavior and Chemsex—A Narrative Review of the Literature

    by Martina Strasser, Theresa Halms, Tobias Rüther, Alkomiet Hasan, Marcus Gertzen

    Chemsex is described as the use of certain drugs—commonly methamphetamine, gamma-butyrolactone (GBL)/gammahydroxybutyrate (GHB), and mephedrone—before or during planned sexual activity primarily among men who have sex with men (MSM). Evidence shows that MSM who engage in chemsex are at increased risk of physical harm, such as sexually transmittable infections (STIs), and are more likely to experience mental health symptoms. To further assess this, we reviewed the recent literature to evaluate whether the psychological impact of chemsex behavior includes suicidal ideation and suicidal attempts. Pubmed/MEDLINE was searched for articles reporting suicidal ideation and behavior among chemsex users with the terms “chemsex”, “sexualized drug use”, “suicide”, and “mental health”. Twelve articles (three case reports and nine cross-sectional studies) were included in the final narrative review. Overall, we retrieved mixed results regarding the relationship between chemsex practice and suicidality outcomes. Considering the inhomogeneous nature of the studies, the findings indicate that suicidality could be an issue of concern among MSM in general but among chemsex users in particular. Possible risk factors for suicidality among chemsex participants may include adversities experienced due to one’s sexual orientation and an increased risk for HIV and other STI infections and the resulting negative impact on mental well-being. These aspects warrant further investigations.